Skip to main content

Fauci ‘cautiously optimistic’ we will have a coronavirus vaccine this year

Dr. Anthony Fauci told a House panel he is “cautiously optimistic” that a coronavirus vaccine will be developed this year.

“We hope that as the time we get into the late fall and early winter we will have, in fact, a vaccine that we can say would be safe and effective,” Fauci, the Director of the National Institute of Allergy and Infectious Diseases, testified before a Democrat led-panel on the outbreak on Friday, July 31. “One can never guarantee the safety or effectiveness unless you do the trial, but we are cautiously optimistic.”

Recent coronavirus vaccine trials have proved promising, with an Oxford developed vaccine triggering immune responses in early human testing. Testing out of China have also produced encouraging results. But the results do not prove the vaccine can prevent coronavirus and further trials would be needed to determine its efficacy against the fast-spreading disease.

Once developed, a vaccine would then need to be mass-produced at a scale of hundreds of millions to properly inoculate the U.S. population.

Coronavirus infections are skyrocketing in the United States, as the number of cases tops 4,400,000. With total deaths over 150,000, according to the CDC, top health experts are hoping for a vaccine to slow a potential second wave of infections in the fall.

President Trump responded to the hearings on Twitter, repeating a false claim that coronavirus cases were spiking due to an increased amount of testing in the U.S. compared to other countries. Public health experts have verified that the percentage of positive test results are rising faster than the increase in testing, proving that the virus is truly spreading.

Editors' Recommendations

Zoe Christen Jones
Zoe Christen Jones is a breaking news reporter. She covers news, digital culture, tech, and more. Previously, she was…
New coronavirus vaccine triggers immune response in early testing
medical employee holding mask stylized image

A coronavirus vaccine developed by Oxford University and drug company AstraZeneca triggered an immune response in early trials, according to a study published on Monday, July 20. 

The vaccine produced strong immune responses in patients inoculated with both single- and two-dose versions of the vaccine. The promising results were first published in the scientific journal The Lancet.

Read more
No, coronavirus can’t be spread by mosquitoes
close up mosquito photos 4

The myth that the coronavirus can spread through mosquitoes has been debunked, according to the results of a new study.

The study — from researchers at the infectious disease lab at Kansas State University's Biosecurity Research Institute — tested three of the most common types of mosquitoes for their potential to carry the novel coronavirus. In 277 insects inoculated with the SARS-CoV-2 virus, researchers were unable to detect virus replication. This led to the conclusion that the mosquito population, while able to host the disease, could not contribute to its transmission, especially to humans, according to the study.

Read more
Google to ban ads from appearing next to coronavirus conspiracy theories
medical employee holding mask stylized image

Google will reportedly ban advertisements from running alongside debunked coronavirus conspiracy theories, starting in August.

Under the new policy, supervisors will be able to remove entire ads from articles, as well as ban all advertisements for websites that violate the new rule on multiple occasions, according to CNBC. Google had previously banned ads that made harmful claims about prevention and treatment of the coronavirus.

Read more